Schizophrenia: a disease of the brain?


The brain is usually considered as the most relevant organ of schizophrenia, but evidence suggests that peripheral tissues also contribute to the disease

The brain is usually considered as the most relevant organ of schizophrenia, but evidence suggests that peripheral tissues also contribute to the disease

Scientists in China have unearthed further evidence that a malfunction of the immune system contributes to the development of schizophrenia.

Schizophrenia is a severe mental illness, which affects around 1% of the world’s population. It is traditionally thought to be exclusively caused by problems in the brain. However, there is a growing body of evidence that suggests that the immune system has an important role to play.

Lin He and Chunling Wan from Shanghai Jiao Tong University, and their colleagues, identified over 1300 proteins in the blood and then compared the blood of schizophrenic patients with healthy blood using mass spectrometry. They found that 27 proteins were different in the schizophrenic patients and that all of these proteins were involved in the complement system.

The complement system is a system of proteins in the blood that are part of signalling pathways in which each molecule activates the next, ‘complementing’ – or enhancing – the body’s immune response. There are three main signalling pathways in the system, which are activated in different ways and involve different molecules. One such pathway is the alternative pathway.

The team backed up their study by showing that the alternative pathway is suppressed in schizophrenic patients. And Yang Li, a member of the team, says that ‘further statistical and bioinformatics analysis indicated that a malfunction of the complement system may be involved in schizophrenia’.

David St Clair, an expert in the causes of schizophrenia at the University of Aberdeen, UK, thinks that the study is interesting and scientifically sound, but that ‘the findings need replicating, preferably in cerebrospinal fluid from patients’.

Li is cautious about the work’s impact. ‘We can't determine whether the alteration of complement pathways is a cause or effect of schizophrenia. The role of complement proteins in the development of the central nervous system also needs further exploration. That's our future research work,’ he says.

 

References

  1. Y Li et al, Mol. BioSyst., 2012, DOI: 10.1039/c2mb25158b

Related Content

Breaking through the barrier

31 May 2011 Feature

news image

Getting drug molecules into the brain means crossing the defensive blood-brain barrier. Anthony King investigates how chemist...

Chemistry World podcast - July 2013

1 July 2013 Podcast | Monthly

news image

Hagan Bayley explains the scientific scope for 3D printing and Chad Mirkin introduces programmable DNA building blocks

Most Commented

Lithium–sulfur batteries ready to go the distance

3 December 2013 Research

news image

Innovative electrodes set to put electric cars in the fast lane with a new design that holds double the energy of ordinary li...

Graphene made in a kitchen blender

22 April 2014 Research

news image

High quality flakes of two-dimensional material exfoliated from graphite points way to bulk production